Centurion Healthcare Private Limited Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Centurion Healthcare Private Limited Pharmaceutical Export Portfolio Dataset — 4 Products, $267.7K FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Centurion Healthcare Private Limited — Pharmaceutical Exporter Profile (2026) | 4 Products, $267.7K Trade | TransData Nexus

Centurion Healthcare Private Limited

Indian Pharmaceutical Exporter · Cardiovascular Specialist · $267.7K Total Trade · DGFT Verified

Centurion Healthcare Private Limited is an Indian pharmaceutical exporter with a total trade value of $267.7K across 4 products in 4 therapeutic categories. Based on 14 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Nitroglycerin ($96.0K), Azathioprine ($93.1K), Benzylpenicillin ($49.7K).

Centurion Healthcare Private Limited — Export Portfolio & Destination Treemap

Centurion Healthcare Private Limited pharmaceutical export portfolio — 4 products across 4 therapeutic categories. Source: Indian Customs (DGFT).

Who is Centurion Healthcare Private Limited? — Company Overview & Market Position

Centurion Healthcare Private Limited, established on October 17, 2012, is a privately held pharmaceutical company headquartered in Vadodara, Gujarat, India. The company is registered under the Corporate Identification Number (CIN) U24232GJ2012PTC072346. Its authorized share capital is ₹25,000,000, with a paid-up capital of ₹2,517,570. The registered office is located at Office No. 601, Unit-A, Atlantis Heights, Wadi Wadi, Vadodara, Gujarat 390003, India. The company employs between 26 to 50 people and has an annual turnover ranging from ₹100 to ₹500 crore. Centurion Healthcare specializes in the manufacturing and export of pharmaceutical products, including tablets, capsules, syrups, injections, and ointments. The company's product portfolio spans various therapeutic categories, such as antimalarial, anti-hypertensives, anti-diabetic, beta-lactam and cephalosporin antibiotics, general antibiotics, analgesics, food supplements, anti-allergics, gastrointestinal agents, central nervous system drugs, anti-cold and cough preparations, anti-fungal, anti-viral, and anti-protozoal agents.

What Does Centurion Healthcare Private Limited Export? — Product Portfolio Analysis

Top Products by Export Value

1Nitroglycerin$96.0K

Product Portfolio — Top 4 by Export Value

Centurion Healthcare Private Limited exports 4 pharmaceutical products across 4 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Nitroglycerin	Cardiovascular	$96.0K	4	1.0%	13
2	Azathioprine	Immunosuppressants	$93.1K	3	0.3%	11
3	Benzylpenicillin	Advanced Antibiotics	$49.7K	4	1.3%	6
4	Lorazepam	CNS & Psychiatric	$28.9K	3	1.2%	9

Centurion Healthcare Private Limited exports 4 pharmaceutical products across 4 therapeutic categories with a total export value of $267.7K. The top category is Cardiovascular (35.9% of portfolio), followed by Immunosuppressants (34.8%), indicating a concentrated portfolio with the top 5 products accounting for 100.0% of total export value.

Centurion Healthcare Private Limited — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

Centurion Healthcare operates a state-of-the-art manufacturing facility in Vadodara, Gujarat, India. The facility is equipped to produce a wide range of pharmaceutical dosage forms, including tablets, capsules, oral liquids, ointments, and injections. The manufacturing processes adhere to international quality standards, ensuring the production of high-quality pharmaceutical products. The company has also been recognized as a Two Star Export House by the Government of India, indicating its significant contribution to pharmaceutical exports.

3Key Leadership

The leadership team at Centurion Healthcare Private Limited includes:

Chetan Patel: Chief Executive Officer (CEO)

Dhruvalkumar Jayantilal Patel: Director

Both individuals have been instrumental in steering the company towards its current position in the pharmaceutical industry.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Centurion Healthcare Private Limited Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Centurion Healthcare Private Limited has made significant strides in obtaining regulatory approvals for its products in various international markets. The company has over 750 formulations registered in different countries, supported by strong regulatory compliance. While specific details regarding approvals from regulatory bodies such as the U.S. Food and Drug Administration (FDA), European Medicines Agency (EMA), Medicines and Healthcare products Regulatory Agency (MHRA), and Therapeutic Goods Administration (TGA) are not publicly disclosed, the company's extensive product registrations suggest a proactive approach to meeting international regulatory standards.

2Emerging Markets

Centurion Healthcare Private Limited has expanded its presence in emerging markets, including regions in Africa, Latin America, and Southeast Asia. The company's commitment to quality is underscored by its WHO-GMP certification, which facilitates access to these markets. Additionally, the company's Two Star Export House recognition by the Government of India reflects its significant export activities, further supporting its expansion into these regions.

3Geographic Strategy

Centurion Healthcare Private Limited — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

Specific details regarding Centurion Healthcare's FDA facility registrations, approved Abbreviated New Drug Applications (ANDAs), Drug Master File (DMF) filings, and inspection history are not publicly available. However, the company's extensive product registrations in various countries and its WHO-GMP certification suggest a commitment to meeting international regulatory standards, which is a prerequisite for FDA approvals.

2WHO & EU GMP

Centurion Healthcare Private Limited holds WHO-GMP certification, indicating compliance with the World Health Organization's Good Manufacturing Practices. This certification facilitates the company's access to international markets and underscores its commitment to quality manufacturing processes. Specific details regarding EU GMP certificates and EDQM status are not publicly disclosed.

3CDSCO & Indian Regulatory

Centurion Healthcare Private Limited operates under the regulatory framework of the Central Drugs Standard Control Organisation (CDSCO) in India. The company holds manufacturing licenses and approvals from state drug controllers, ensuring compliance with Indian pharmaceutical regulations. Additionally, the company's Two Star Export House recognition by the Government of India reflects its significant contribution to pharmaceutical exports.

Centurion Healthcare Private Limited — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

Centurion Healthcare Private Limited operates in a competitive pharmaceutical industry, with numerous players offering similar products across various therapeutic categories. While specific market share data is not publicly available, the company's focus on high-demand products such as Nitroglycerin, Azathioprine, Benzylpenicillin, and Lorazepam positions it favorably in the market. The company's WHO-GMP certification and Two Star Export House recognition further enhance its competitive standing.

2Key Differentiators

Centurion Healthcare's key differentiators include its extensive product portfolio, with over 750 formulations registered in different countries, and its commitment to quality, as evidenced by its WHO-GMP certification. The company's Two Star Export House recognition by the Government of India underscores its significant contribution to pharmaceutical exports. These factors collectively enhance the company's competitive advantages in the global pharmaceutical market.

3Strategic Position

Centurion Healthcare Private Limited's strategic direction focuses on manufacturing and exporting a diverse range of pharmaceutical products, with a particular emphasis on high-demand therapeutic categories. The company's WHO-GMP certification and Two Star Export House recognition reflect its commitment to quality and international market expansion. Future outlooks suggest continued growth in emerging markets and potential diversification of its product portfolio to meet evolving global healthcare needs.

Buyer Due Diligence Brief — Evaluating Centurion Healthcare Private Limited as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Centurion Healthcare Private Limited demonstrates a strong track record in pharmaceutical manufacturing and export, with a diverse product portfolio and a commitment to quality. The company's WHO-GMP certification and Two Star Export House recognition indicate reliability and adherence to international standards. The export data, showing a total export value of $268K USD across 14 shipments, reflects consistent export activity. The company's focus on high-demand products and emerging markets further underscores its reliability as a supplier.

2Certifications to Verify

Importers should verify the following certifications to ensure product quality and regulatory compliance:

WHO-GMP Certification: Confirms adherence to the World Health Organization's Good Manufacturing Practices.

Two Star Export House Recognition: Indicates significant contribution to pharmaceutical exports, as recognized by the Government of India.

These certifications can typically be verified through official government portals or by contacting the certifying bodies directly.

Frequently Asked Questions — Centurion Healthcare Private Limited

How many pharmaceutical products does Centurion Healthcare Private Limited export from India?

Centurion Healthcare Private Limited exports 4 pharmaceutical products across 4 therapeutic categories. The top exports are Nitroglycerin ($96.0K), Azathioprine ($93.1K), Benzylpenicillin ($49.7K), Lorazepam ($28.9K). Total export value is $267.7K.

What is Centurion Healthcare Private Limited's total pharmaceutical export value?

Centurion Healthcare Private Limited's total pharmaceutical export value is $267.7K, based on 14 verified shipments recorded in Indian Customs (DGFT) data.

What therapeutic categories does Centurion Healthcare Private Limited cover?

Centurion Healthcare Private Limited exports across 4 therapeutic categories. The largest are Cardiovascular (35.9%, 1 products), Immunosuppressants (34.8%, 1 products), Advanced Antibiotics (18.6%, 1 products).

Get Full Centurion Healthcare Private Limited Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.